Cantor Fitzgerald Starts Oncternal Therapeutics (ONCT) at Overweight
Tweet Send to a Friend
(Updated - December 22, 2022 6:32 AM EST)
Cantor Fitzgerald analyst Li Watsek initiates coverage on Oncternal Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cantor Fitzgerald analyst Li Watsek initiates coverage on Oncternal Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
